[go: up one dir, main page]

DE60313754D1 - Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin - Google Patents

Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin

Info

Publication number
DE60313754D1
DE60313754D1 DE60313754T DE60313754T DE60313754D1 DE 60313754 D1 DE60313754 D1 DE 60313754D1 DE 60313754 T DE60313754 T DE 60313754T DE 60313754 T DE60313754 T DE 60313754T DE 60313754 D1 DE60313754 D1 DE 60313754D1
Authority
DE
Germany
Prior art keywords
isoliquiritigenin
compositions
anticipative
activity including
botanical extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60313754T
Other languages
English (en)
Other versions
DE60313754T2 (de
Inventor
Sophie Chen Ph D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDICAL RES AND EDUCATION TRUS
Original Assignee
MEDICAL RES AND EDUCATION TRUS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDICAL RES AND EDUCATION TRUS filed Critical MEDICAL RES AND EDUCATION TRUS
Application granted granted Critical
Publication of DE60313754D1 publication Critical patent/DE60313754D1/de
Publication of DE60313754T2 publication Critical patent/DE60313754T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60313754T 2002-03-06 2003-03-06 Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin Expired - Lifetime DE60313754T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36242002P 2002-03-06 2002-03-06
US362420P 2002-03-06
US37441702P 2002-04-22 2002-04-22
US374417P 2002-04-22
PCT/US2003/006979 WO2003075943A2 (en) 2002-03-06 2003-03-06 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol

Publications (2)

Publication Number Publication Date
DE60313754D1 true DE60313754D1 (de) 2007-06-21
DE60313754T2 DE60313754T2 (de) 2008-01-24

Family

ID=27807965

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60313754T Expired - Lifetime DE60313754T2 (de) 2002-03-06 2003-03-06 Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin

Country Status (5)

Country Link
EP (1) EP1487434B1 (de)
AT (1) ATE361746T1 (de)
AU (1) AU2003217982A1 (de)
DE (1) DE60313754T2 (de)
WO (1) WO2003075943A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
DE10394175T5 (de) * 2003-03-06 2006-08-03 The Medical Research and Education Trust, San Diego Zusammensetzung mit einem botanischen Extrakt mit Anti-Krebs- oder phytoöstrogener Aktivität, enthaltend Prenyflavonoide
KR100437274B1 (ko) * 2003-10-15 2004-06-24 주식회사 케이엠에스아이 연골재생제로서 아피제닌을 함유하는 골관절염 치료 조성물
CN1329083C (zh) * 2004-03-11 2007-08-01 上海第二医科大学附属瑞金医院 一种降解aml1－eto融合蛋白的方法及所用试剂
WO2006024545A1 (en) * 2004-09-03 2006-03-09 Stichting Voor De Technische Wetenschappen Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes
FR2886151B1 (fr) * 2005-05-31 2007-09-07 Mayoly Spindler Soc Par Action Utilisation de la colchicine pour la preparation d'un medicament destine a la prevention et/ou au traitement de l'endometriose
CN101669935B (zh) * 2005-10-25 2013-12-11 上海医药工业研究院 一种含樱黄素的药物组合物及其在制药中的应用
JP2009541324A (ja) * 2006-06-20 2009-11-26 メタプロテオミクス， エルエルシー 還元型イソアルファ酸に基づくタンパク質キナーゼ調節癌治療
US20090012031A1 (en) 2007-07-03 2009-01-08 The Regents Of The University Of Michigan EZH2 Cancer Markers
CN104771395A (zh) 2010-03-31 2015-07-15 株式会社爱茉莉太平洋 含有香豆雌酚或包含香豆雌酚的豆提取物的组合物
WO2014047780A1 (zh) * 2012-09-25 2014-04-03 鼎泓国际投资（香港）有限公司 含有芹菜素及芹菜素类衍生物和冬凌草甲素及冬凌草甲素类衍生物的药物组合物及其应用
CN104059079A (zh) * 2013-03-22 2014-09-24 海南大学 一种猪屎豆碱的提取方法
AU2015324072B2 (en) * 2014-09-29 2018-12-06 The Penn State Research Foundation A compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73
CN104237536A (zh) * 2014-10-14 2014-12-24 厦门大学 黄酮类化合物刺槐素及衍生物的用途
CN105381068A (zh) * 2015-11-27 2016-03-09 黄平县兴且民族民间中草医药科学发展有限责任公司 一种用于固齿消炎的中药
KR102004593B1 (ko) * 2016-12-20 2019-07-26 고려대학교 산학협력단 쿠메스트롤을 포함하는 상피성 난소암 예방 또는 치료용 약학적 조성물
CN108452293A (zh) * 2018-04-12 2018-08-28 广西达庆生物科技有限公司 一种妇科用凝胶及其制备方法
CN111837960A (zh) * 2020-08-05 2020-10-30 贵州茗香茶业发展有限公司 一种适用于喀斯特地貌金丝黄菊的育种方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476016A (en) * 1975-07-31 1977-06-10 Nippon Shinyako Co Ltd Pharmaceutical compositions having anti-tumour activity
JPS52145509A (en) * 1976-05-27 1977-12-03 Tokutarou Matsui Antitumor agent
JPS60178815A (ja) * 1984-02-24 1985-09-12 Rikagaku Kenkyusho 制癌剤
CA1289077C (en) * 1984-08-13 1991-09-17 Harry H. Leveen Treatment of cancer with phlorizin and its derivatives
JPS61263925A (ja) * 1985-05-20 1986-11-21 Kanebo Ltd 制癌補助剤
JPH02255622A (ja) * 1989-03-28 1990-10-16 Tsumura & Co 制癌補助剤
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
FR2658420A1 (fr) * 1990-02-19 1991-08-23 Gaudeau Claude Medicaments a base d'atractylis gummifera et varietes alba, lyrata, ovata, humilis, cancellata et leurs derives dans le traitement des pathologies cancereuses de pathologies inflammatoires et pathologies immuno-depressives.
JPH04283518A (ja) * 1991-03-12 1992-10-08 Kikkoman Corp 抗歯周症剤
JPH0624975A (ja) * 1992-05-12 1994-02-01 Dainippon Ink & Chem Inc 制癌活性増強剤
JPH06172195A (ja) * 1992-12-03 1994-06-21 Tsumura & Co Ｕｄｐ−グルクロニルトランスフェラーゼ阻害剤
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
JPH08104628A (ja) * 1994-10-04 1996-04-23 Sumitomo Pharmaceut Co Ltd マトリックスメタロプロテアーゼ阻害剤
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
EP0850055B1 (de) * 1995-09-11 2005-06-29 Osteoarthritis Sciences, Inc. Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
JPH09176011A (ja) * 1995-12-27 1997-07-08 Kureha Chem Ind Co Ltd Ｈｓｐ２７ファミリーに属するタンパク質のフラボノイド含有合成抑制剤
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
JPH10114653A (ja) * 1996-10-11 1998-05-06 Taishi Shokuhin Kogyo Kk 骨形成促進および骨塩量減少防止用組成物
WO1998048790A1 (en) * 1997-04-28 1998-11-05 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
FR2781154B1 (fr) * 1998-07-15 2001-09-07 Lafon Labor Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
FR2781153B1 (fr) * 1998-07-15 2001-08-03 Lafon Labor Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
GB2346325A (en) * 1999-02-02 2000-08-09 Wassen Int Ltd Formulation comprising a brassica extract or sulforaphane and resveratrol
DE19906016A1 (de) * 1999-02-16 2000-08-17 Green Power Internationalprodu Zubereitung für oral zu verabreichende Nahrungsergänzungs- und/oder Arzneimittel in Form von Tabletten
JP4112730B2 (ja) * 1999-02-22 2008-07-02 オリザ油化株式会社 口腔用抗菌剤
EP1194156B1 (de) * 1999-07-09 2006-04-12 Sun Farm Corporation Diätzusatz zur behandlung von malignitäten und virusinfektionen und verbesserung der immunfunktion
AU7592100A (en) * 1999-09-20 2001-04-24 Stephen J. Currier Standardized functional food products
JP2001114675A (ja) * 1999-10-12 2001-04-24 Fancl Corp ビタミン組成物
WO2001030342A1 (en) * 1999-10-20 2001-05-03 Board Of Trustees Of Southern Illinois University Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
EP1127572A3 (de) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Verwendung von Flavonen zur Behandlung von Cyclooxygenase-2 ermittelten Krankheiten
CN100490845C (zh) * 2000-03-09 2009-05-27 耶鲁大学 一种草药组合物及其在化疗中的应用
ES2267741T3 (es) * 2000-03-15 2007-03-16 Chemgenex Pharmaceuticals, Inc. Composiciones combinadas de alcaloides de cefalotaxina y de los mismos.
WO2001078783A2 (en) * 2000-04-17 2001-10-25 Hauser, Inc. Compositions comprising natural agents for treatment of cancer
WO2001080855A1 (en) * 2000-04-27 2001-11-01 Geron Corporation Telomerase inhibitors and methods of their use
DE10053496A1 (de) * 2000-10-27 2002-05-08 Peter Fuerst Zusammensetzungen enthaltend Flavonoide und Phloridzin oder Phloretin
US20030035851A1 (en) * 2001-02-08 2003-02-20 Sophie Chen Anti-cancer agents and method of use thereof
UY27220A1 (es) * 2001-03-23 2002-09-30 Aventis Pharma Sa Combinación de un taxano con una quinasa ciclina-dependiente
US20040152640A1 (en) * 2001-03-23 2004-08-05 Van Helvoort Adrianus Lambertus Bertholdus Preparation for the prevention and or treatment of altered bone metabolism
ATE319462T1 (de) * 2001-04-02 2006-03-15 Hongfen Li Antineoplastisches arzneimittel
WO2002080951A1 (en) * 2001-04-06 2002-10-17 Synergistix Biotech, Inc. Herbal extracts for the treatment of cancer
DE10118999A1 (de) * 2001-04-18 2001-11-08 Fritz Reiners Verwendung von hormonfreien Kombinationspräparaten zur Vorbeugung und Behandlung von klimakterischen Beschwerden bei Männern
US20030165588A1 (en) * 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors

Also Published As

Publication number Publication date
AU2003217982A8 (en) 2003-09-22
EP1487434B1 (de) 2007-05-09
ATE361746T1 (de) 2007-06-15
WO2003075943A2 (en) 2003-09-18
AU2003217982A1 (en) 2003-09-22
DE60313754T2 (de) 2008-01-24
WO2003075943A3 (en) 2004-04-22
EP1487434A2 (de) 2004-12-22

Similar Documents

Publication Publication Date Title
DE60313754D1 (de) Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
NO20014842L (no) Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft
MXPA03010121A (es) Terapia de combinacion que utiliza anticuerpos anti-receptor de factor de crecimiento epidermico y agentes anti-hormonales.
TW200612987A (en) Combination treatment for non-hematologic malignancies
BR0315337A (pt) Composto, formulação farmacêutica, e, método para tratar câncer
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
WO2002058694A3 (en) Method of treating hematologic tumors and cancers using beta lapachone
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DE60124387D1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
GB2415905A (en) Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising prenyl flavonoids
IL164564A0 (en) Combination therapy for the treatment of cancer
EP1808172A3 (de) Zusammensetzungen mit botanischen Extrakten und Verwendungsverfahren
BR0316010A (pt) Combinação
DK1161254T3 (da) Behandling af autoimmune sygdomme med en ekstrakt af amerikansk ginseng
BRPI0409870A (pt) uso de irinotecano para tratamento de cáncer de mama resistente
NO20055888L (no) Kombinasjonsterapi
WO2002094183A3 (en) A method for tumor treatment with fumagillol derivatives
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
MD1610F1 (en) Method of the recidivating chronic aphthous stomatitis treatment
WO2004017919A3 (en) Use of mullerian inhibiting substance and interferon for treating tumors
WO2007067753A3 (en) Methods of reducing side effects in cancer therapy
BRPI0416019A (pt) uso de siramesina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, kit, e, método para o tratamento de cáncer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition